- Bloom Health Partners (BLMH) has begun to wind down its operations
- The decision is in response to reduced demand for its services, as well as broader market pessimism
- All operations will cease by year-end following testing support commitments in Hawaii
- Bloom Health Partners offers a global platform for healthcare security, diagnostic testing and occupational health technology
- Bloom Health (BLMH) closed unchanged, trading at $0.08 per share
Bloom Health Partners (BLMH) has begun to wind down its operations.
The decision is in response to reduced demand for its services, as well as broader market pessimism.
The company is in the process of reducing expenditures to preserve available capital. It is also in discussions with creditors to reduce or eliminate outstanding obligations.
Bloom Health will continue to provide testing support in Hawaii through 2022 with a significantly reduced workforce, following which all operations will cease.
The remaining directors are expected to tender their resignations on or about November 15, 2022.
Bloom Health Partners offers a global platform for healthcare security, diagnostic testing and occupational health technology.
Bloom Health (BLMH) closed unchanged, trading at $0.08 per share.
